Page 1 of Clinical Trials for ( Sirtris AND a GSK Company ) [SPONSOR-COLLABORATORS], 12 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis
Last Updated: February 16, 2012
Condition(s): Psoriasis
2
Completed
A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic Metastases
Last Updated: August 4, 2011
Condition(s): Neoplasms, Colorectal; Colorectal Cancer
3
Completed
A Clinical Trial to Assess the Safety of Oral SRT2104 and Its Effects on Vascular Dysfunction in Otherwise Healthy Cigarette Smokers and Subjects With Type 2 Diabetes Mellitus
Last Updated: January 5, 2012
Condition(s): Diabetes Mellitus, Type 2
4
Completed
Effect of SRT2379 on Endotoxin-Induced Inflammation
Last Updated: July 26, 2011
Condition(s): Sepsis
5
Completed
A Study in Healthy Male Volunteers to Investigate Different Doses of a New Drug for the Treatment of Metabolic Diseases
Last Updated: February 16, 2012
Condition(s): Diabetes Mellitus, Type 2
6
Completed
Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Type 2 Diabetic Human Subjects
Last Updated: December 1, 2011
Condition(s): Diabetes Mellitus, Type 2
7
Completed
A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Normal Healthy Male Volunteers
Last Updated: August 4, 2011
Condition(s): Diabetes Mellitus, Type 2; Healthy Volunteer
8
Terminated
A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple Myeloma
Last Updated: March 29, 2012
Condition(s): Multiple Myeloma
9
Completed
A Clinical Study to Evaluate the Pharmacokinetics and the Absolute Bioavailability of SRT2104 Given as a 250mg Oral Suspension and Intravenous Microdose of 100 µg Carbon-14 Radio-labeled SRT2104 in Healthy Male Subjects
Last Updated: August 4, 2011
Condition(s): Diabetes Mellitus, Type 2; Healthy Volunteer
10
Completed
A Clinical Study to Assess the Effect of Food and Gender on the Pharmacokinetics of SRT2104 Administered as an Oral Suspension or Capsule Formulation to Normal Healthy Volunteers
Last Updated: August 4, 2011
Condition(s): Diabetes Mellitus, Type 2; Healthy Volunteer
11
Completed
Effect of Multiple Dose Levels of SRT2379 on Endotoxin-Induced Inflammation
Last Updated: February 16, 2012
Condition(s): Sepsis
12
Recruiting
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
Last Updated: April 5, 2012
Condition(s): Colitis, Ulcerative

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Sirtris%2C+a+GSK+Company

Page 1 of Clinical Trials for ( Sirtris AND a GSK Company ) [SPONSOR-COLLABORATORS], 12 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About